{"ticker": {"uuid": "7388c806-6af8-483e-bfe9-4089dbc8e7da", "symbol": "BIIB34", "name": "Biogen Inc.", "exchange": "SAO", "country": "BR", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Biogen Inc (BIIB) Shares Fall 8.2% -- What GF Score of 74 Tells Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxObGpNQzlXbDk0NF8zQ3p1T0hsUHJtTUdmaTRkbllaQkpzSTdudUtCUmt5N1pBUHNBTkZHUzB4OVlYZHFOS0pTS0ZGN3JqZEt2UEpNZkVrMUdXQWNHTzJUbXdhblJCd1dtbjF4elk1Nm95MDlYVHluemJiSlk0bkJPOGlMQjZmSEFVQ2E1NjhGYWsxNnplUjVxWXQ2SmN4REZRWllnNzFZQ2Q?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-14T22:01:21+00:00", "published_display": "14 Jul 2026 22:01", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Needham reiterates Buy on Biogen stock after RayThera acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNanM2aEVsWURNd012VFppaHJGUUk3Z1RJMXY2eG00Q19CUzRtOFNBMXVlVzVTR3FqNFhWUk9JTWRiQXhTUTJrMFpvdnVBQWFnQzV4elVGTjU1d2NydDJEaGFOaENvN3JYdUtwNUlxa3VrVlhnUnRGeW9TYUhNUzQwRWR2ZTFkX0JKXzIzczVRRTE3LXdHNXdJNFNaVXZZS0p3dnNwTnp4VE9JQkxCY0F4azc0ZmpnZ09YWkUtdG85bkNGc00?oc=5", "source_name": "Investing.com", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNYzAtRGZ1NXQxMGFYMy1CdElVRHRTMjhjajJlX2U4WmxjMzhneWRVb2hfSkpxNDJ2emRqYTE1MmlDQ2p0VzlwV1Z3a1htbVhXRzlleTB3VFlMR21yZ2hrT0t0YmE3Z19sMWFCQTNRUlBodGRWZzZKTHFndUFMdzBtb0taakYtVFJlSE9EczhwYWNlUzAtMERMR19HN2c1SnpSQ2w0YnhBUDVXdTJXXzZHU3RXb1FTYzJuUDRDbm15ejVfUVlVYzRjNnZzRmczenBqcUhhR2lDMm9QN3p4aWxtb25JRXNEMXpZ?oc=5", "source_name": "PR Newswire", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNc0RqN0ZqUGNwMHBUdDhPcDlKYkdpWG5vc3ZfVUpQckMxbVdLLUhQVi1SMUlXRlpCMGZGb013VEJzcUdldi1sTzkwcFh3ZE03aDFsakIwWXlGbGxLRXhBVUxoQzRVN3BNekY1UTR2QmdzMXpLa01Mc0dVcXRlSUpQV0lta0hDVXc4cFM0eWxwV0tOdkV2ZU1XTWVrQ1U2LTdGTmlQNWQtZlNaNTQ1N2lQTEtmRlhzek1EblhUMlhqS3VTTWc?oc=5", "source_name": "Biogen", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FMR LLC's Strategic Acquisition of Biogen Inc Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOdnBfaG1FRVZkWHJ3WmJkRXVWSzhNeFRGWGZBYzZxOTlsMmktMTl6OFBjTnlUb3RKT1BxcVFxdFVad003a05SSlFmUVdlbDQwcloxY095YXItZUhzZl9hX2RPdGNWUS1DVWdISnBZQWRJNmxGOVFQUTl6VGFaQWtRUUx6M3ZZb185d3FCNW1Bakp4Nmc4QkFNZzJTZy1NRHRYQmtKVQ?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BIIB SHAREHOLDER INVESTIGATION: SueWallSt Investigates Biogen Inc. for Possible Securities Law Violations", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxQRUM1WVEtenFuMTBGT0IyMzU2U0c4RWgxNFlSS0RUSWdrSWdDS2s2djJ6NkpjZWFQUFU5dF9JS3RVN24xRDZpNlhqS0J6dTJxYlJjVHFhbG1ocE1ZcGVyVWFfNjhVbEotQlZhd0s3SEVwelhjTWd5azYwTE1qN1dvUUJmb2pkTm1NZmxVUWtGZUhNUVBEdnhCeVIwTjdWYXNYMkZibEZ6ODFUNDBBMHlsTHZPVFJlUEZOa3hpa1JvSmhMRHIyVldpb1QydVpFV0NjbDJkczYtaDlwSE5KRUFUbE5PbW5jYUxVSXp2NWVZeTE?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore ISI reinstates Biogen stock with Outperform rating", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQVW5BRlhvdERZM29oUGRXZU9WOUU5aEVibmZsSDFFcllISENqX0I1RXVxOUZDWmtCZUxtZnJzNE1DR3RTWHVFV2RuSnphdjNnSHJ2Y1lTZzFoX2d5YWplenFFVEpld0UtX1B1T3RuYmdlUmVCUG0yV2xKWXoyd3oyNDNiSkpld3Y4QXZiMVBmd2x4YWJEamRxRlNvTXY4WU41NzliRnRaOFUtTXZNWVg0dklPS2RZbGw3U2pN?oc=5", "source_name": "Investing.com", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Acquisition of Apellis Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOZ256enZtNjcySFlVRFVBdlVmVlIxLVFUYVZGVVJCMWJyaEVwaG1XSFdrOWxZU3ZDWGtiZmVUNkRtSmtKeTIyaldoQ2xuQ3JzaXdQeUNteGZOM3hZYzI5UUJ0MXVYNDBjVGZrSldQQUFSaF9MUUphR1lyX3daMl9pODJkdGU1NWRLM0NLRDlvelJmOEkzYV92VkY1TE1qWEFXV3dyWW1FeGJObnowT0VfUlRISFR0YXc?oc=5", "source_name": "Biogen", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen stock hits 52-week high at $202.64", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNcW51Ty1ISTFQUzQ4Q0JfWmFXb2ZyVUJfbGU0dnJYVDE5QlRDZ1RkcVQ1YUFFYWVXRHdQOFpoRzlxNmxsMC0wN2JqYWVfNlhLanlQQTZqTXdFaG54S09PRUFPbXI5dkdGdV9DbUJJMFNfNC00Zmd0MC1kbElaTTdmQWU2a2pMRTgyZ3JtRTc3czlMZEtxSmd4NVVBTQ?oc=5", "source_name": "Investing.com", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Participate in the Bank of America Securities 2026 Health Care Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPV09Ub1IzblUzZVVHM2NaZHFOMFB4TEZuYXhlZG9FUENtUG94MXVpdkc5SjF3TEt5bk1ZTmh6cHNvWEgtb0NjS2xvcVZSQ09HTmtmQmRLNXkwRVVNUlBCWldteHdTc0lsOW1MMl9JLUlwRTFUMXpHQV9nU2RSNDFpNDgxSGFGTmdZTWR1TnB1T3pKWWhfU3ZVTU1RQzd3WkE4NV9KSGV2YTRXY0lmNlY1M0xpNGlqWmZYVlN1dW02bmk?oc=5", "source_name": "Biogen", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen stock price target raised to $245 by Canaccord on Apellis deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPVnB0QjJjZlNOZTRjcnUwUU43N2M0Z2x4OW5LcVVTTmUwSWN6UmpSaWcwRzYwMDdLb0hsTkl4Mzc2U2poTUYzYkhjTTdaSjcwVEJ1cFV4U01ScG9jMWhsZ2VCU2lfQlloVk0xVVN5ODR5SWFJVzV0NWQxRzdnX1luOEtXai03M1BFdjM5VHZnT0czZGR1UzRJTnZBTHE2REh6b3RmUTZkR0ZkWnhRZjRkUG9HRzhJdDRNMlF0eUtRemloLXFMMFRF?oc=5", "source_name": "Investing.com", "published_at": "2026-04-01T07:00:00+00:00", "published_display": "01 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 64, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Acquire Apellis, Enhancing the Company\u2019s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOVEV0VlhLbzVMaGdWYjJJLVN4V0NIVnVidDk2NW9vRzVpTTNwVDBZTl9aQW9Xd0FKQ3JTeXBvcUZpSTFQNHEwN3NRX1FTeUdfdVNlYWpDZlREb1lOd0RVemRNUG5WRnlHN3R1czVXN2NteVFqeV9hYzZybXZZWVkwTDZSNlFrQmJtNFBOUjZqZU9jRXFRRmFhNE1oNkVfM1ZrWEFIZ2FQclpuYmRYV09jVDdGSDZKZ1BPYnhXZHNIZw?oc=5", "source_name": "Biogen", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to acquire Apellis Pharmaceuticals for $5.6B, adding C3 therapies to portfolio", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxPeTYyQXlmLXRZbEJRVURhb2tITmUzcWxfMUhiSjRCRjkxajItRGgyMDlxdUs3MG1wT3NpdUNhZUxCQzVpSVQzMTZuZjlhN1ZxazBiMHFveXBYbFhMSEJiUGNtb1JfSUpzQ3YzQ1l4SzBHTnp5STVMTFpNd05WSkk3c0xVelhfWmhDWjJ5QUc0QVhpNHpSekVmNnZpM1VkYjdDLVgtZllVVmpoLWFaZkp6U29sY0tyT1FKYVBqR29CTTdsb3BpMG1EVkM2UzlKTC1fM01YbGxYYWljRlZwZWNkN0JOV0xuZm1fRmc?oc=5", "source_name": "Proactive financial news", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Apellis Pharma Skyrockets on Biogen Deal. Is It Too Late to Chase APLS Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPakpLRXlsYVRWR0hmV0lxTm54MmVhZFQ1Nzg5V1owMnhSY2g3S3ROQTNnQUQ3UTlvWnZmdC16RkhPUXRaUGszeEdMMmxiUzVqMmdfSFc0MUdIT3Zva2lwdXNlMjQtS1ZsNFBoNWlJTzAyQ0tqVG44TjNNVnFOY2dLSENXajJ0Q2EzQ3A2c21KV2U1ekJRd3R2Nko5bUhBUEtGWGllMVU0U2dSRGFaNV9lY01JZ003SVFFWkZV?oc=5", "source_name": "Barchart.com", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen stock maintained at Buy by Jefferies on FDA Spinraza approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQenh4ZjE3VG9abkY1c0xnOTJFUEkzaTlWSDFqYTdYeVYtd1FKd2MyaVc0UlNSalJPdHRaR1dBdnNkUnhOVjJXZW9zcU95UWhPc0dCT3o0SjZzVlQyQXAtWTBHUFBGeW1fRHpiX1I2aHZnY3lSMVhGU2tvNkowTWtleXVROXRrTFdaak9LY3F4OXhadHdvVDRxRHJfdlpYMXkyRTBQN0NlUG0yZ1l2dnJXZGhobGpPM01QMi12ZC03NElnVW02aWQw?oc=5", "source_name": "Investing.com", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Stock: Is BIIB Outperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQV0JiVkxRdFA1THhONXZiQmJGUE43bk9lRlNCOEVEOHU5ZFBPTUlVLWFQTUk4NUk1eEtFekN4WXVWN3BPSkxkeTNKU1pJN0ZjSjRnU3R5OENncDJ6TDJFSVliTnpjemxla2hSNmlnX05LUGNPdDdFNzUzRnJwNlZpM3BoQWhhUGRxTC1wZ0FRRm9DNjN4clFOLVVDbWNxZjBY?oc=5", "source_name": "Barchart.com", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Share New SMA Data at Muscular Dystrophy Association and SMA Europe Conferences", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNRWZUUFdGSnJzeUhKM19mMGtuODF6NW11UTNfYTV2amdxT25zR1VQWlIyLVhtTUswV1VOWDR4cUNPRUFPdkJvOGo0cWxRUjBNN2NOaDg2Nk9UYlRseUVwWnkwWmpnNUFsMUVhOXYtcEtGRHM5MlJOVjhTYnJRX1NuQWxTX282ZDQ4Q0t2TVJJbTFYZ09fT2NYeG5pUVZiVzVLS2xwMldxWnBjTVFEZnF4aTlna0lMbUJ1N1FLWHRRYXhaalNNel93?oc=5", "source_name": "Biogen", "published_at": "2026-03-05T12:32:19+00:00", "published_display": "05 Mar 2026 12:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Acquisition of Alcyone Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNOGRybmhqVmpTUUxzQ2xtbEllRDNCdjdyREVVbjdyUEp1XzFaVl9zaFN2TUV2b1YtQXZLY0p2Ulc0eG9BaE9ZdDJ3SlJFVUczMzJMYXZFRHlmMlF1cG42V1RIY0ZLNmI4N2pIVFRLc2VLSGxrX0JVNGVybF9XRV9ZZFdMZXMtS3JNNGh4X3FqdDFqUUxLSWkzYTJiZFh0T3ItaTMxWGRmV0JSSUpKcWxoYjhnbw?oc=5", "source_name": "Biogen", "published_at": "2025-11-14T08:00:00+00:00", "published_display": "14 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Biogen Inc (BIIB) Shares Fall 8.2% -- What GF Score of 74 Tells Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxObGpNQzlXbDk0NF8zQ3p1T0hsUHJtTUdmaTRkbllaQkpzSTdudUtCUmt5N1pBUHNBTkZHUzB4OVlYZHFOS0pTS0ZGN3JqZEt2UEpNZkVrMUdXQWNHTzJUbXdhblJCd1dtbjF4elk1Nm95MDlYVHluemJiSlk0bkJPOGlMQjZmSEFVQ2E1NjhGYWsxNnplUjVxWXQ2SmN4REZRWllnNzFZQ2Q?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-14T22:01:21+00:00", "published_display": "14 Jul 2026 22:01", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Needham reiterates Buy on Biogen stock after RayThera acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNanM2aEVsWURNd012VFppaHJGUUk3Z1RJMXY2eG00Q19CUzRtOFNBMXVlVzVTR3FqNFhWUk9JTWRiQXhTUTJrMFpvdnVBQWFnQzV4elVGTjU1d2NydDJEaGFOaENvN3JYdUtwNUlxa3VrVlhnUnRGeW9TYUhNUzQwRWR2ZTFkX0JKXzIzczVRRTE3LXdHNXdJNFNaVXZZS0p3dnNwTnp4VE9JQkxCY0F4azc0ZmpnZ09YWkUtdG85bkNGc00?oc=5", "source_name": "Investing.com", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNYzAtRGZ1NXQxMGFYMy1CdElVRHRTMjhjajJlX2U4WmxjMzhneWRVb2hfSkpxNDJ2emRqYTE1MmlDQ2p0VzlwV1Z3a1htbVhXRzlleTB3VFlMR21yZ2hrT0t0YmE3Z19sMWFCQTNRUlBodGRWZzZKTHFndUFMdzBtb0taakYtVFJlSE9EczhwYWNlUzAtMERMR19HN2c1SnpSQ2w0YnhBUDVXdTJXXzZHU3RXb1FTYzJuUDRDbm15ejVfUVlVYzRjNnZzRmczenBqcUhhR2lDMm9QN3p4aWxtb25JRXNEMXpZ?oc=5", "source_name": "PR Newswire", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNc0RqN0ZqUGNwMHBUdDhPcDlKYkdpWG5vc3ZfVUpQckMxbVdLLUhQVi1SMUlXRlpCMGZGb013VEJzcUdldi1sTzkwcFh3ZE03aDFsakIwWXlGbGxLRXhBVUxoQzRVN3BNekY1UTR2QmdzMXpLa01Mc0dVcXRlSUpQV0lta0hDVXc4cFM0eWxwV0tOdkV2ZU1XTWVrQ1U2LTdGTmlQNWQtZlNaNTQ1N2lQTEtmRlhzek1EblhUMlhqS3VTTWc?oc=5", "source_name": "Biogen", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FMR LLC's Strategic Acquisition of Biogen Inc Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOdnBfaG1FRVZkWHJ3WmJkRXVWSzhNeFRGWGZBYzZxOTlsMmktMTl6OFBjTnlUb3RKT1BxcVFxdFVad003a05SSlFmUVdlbDQwcloxY095YXItZUhzZl9hX2RPdGNWUS1DVWdISnBZQWRJNmxGOVFQUTl6VGFaQWtRUUx6M3ZZb185d3FCNW1Bakp4Nmc4QkFNZzJTZy1NRHRYQmtKVQ?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BIIB SHAREHOLDER INVESTIGATION: SueWallSt Investigates Biogen Inc. for Possible Securities Law Violations", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxQRUM1WVEtenFuMTBGT0IyMzU2U0c4RWgxNFlSS0RUSWdrSWdDS2s2djJ6NkpjZWFQUFU5dF9JS3RVN24xRDZpNlhqS0J6dTJxYlJjVHFhbG1ocE1ZcGVyVWFfNjhVbEotQlZhd0s3SEVwelhjTWd5azYwTE1qN1dvUUJmb2pkTm1NZmxVUWtGZUhNUVBEdnhCeVIwTjdWYXNYMkZibEZ6ODFUNDBBMHlsTHZPVFJlUEZOa3hpa1JvSmhMRHIyVldpb1QydVpFV0NjbDJkczYtaDlwSE5KRUFUbE5PbW5jYUxVSXp2NWVZeTE?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore ISI reinstates Biogen stock with Outperform rating", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQVW5BRlhvdERZM29oUGRXZU9WOUU5aEVibmZsSDFFcllISENqX0I1RXVxOUZDWmtCZUxtZnJzNE1DR3RTWHVFV2RuSnphdjNnSHJ2Y1lTZzFoX2d5YWplenFFVEpld0UtX1B1T3RuYmdlUmVCUG0yV2xKWXoyd3oyNDNiSkpld3Y4QXZiMVBmd2x4YWJEamRxRlNvTXY4WU41NzliRnRaOFUtTXZNWVg0dklPS2RZbGw3U2pN?oc=5", "source_name": "Investing.com", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Acquisition of Apellis Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOZ256enZtNjcySFlVRFVBdlVmVlIxLVFUYVZGVVJCMWJyaEVwaG1XSFdrOWxZU3ZDWGtiZmVUNkRtSmtKeTIyaldoQ2xuQ3JzaXdQeUNteGZOM3hZYzI5UUJ0MXVYNDBjVGZrSldQQUFSaF9MUUphR1lyX3daMl9pODJkdGU1NWRLM0NLRDlvelJmOEkzYV92VkY1TE1qWEFXV3dyWW1FeGJObnowT0VfUlRISFR0YXc?oc=5", "source_name": "Biogen", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen stock hits 52-week high at $202.64", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNcW51Ty1ISTFQUzQ4Q0JfWmFXb2ZyVUJfbGU0dnJYVDE5QlRDZ1RkcVQ1YUFFYWVXRHdQOFpoRzlxNmxsMC0wN2JqYWVfNlhLanlQQTZqTXdFaG54S09PRUFPbXI5dkdGdV9DbUJJMFNfNC00Zmd0MC1kbElaTTdmQWU2a2pMRTgyZ3JtRTc3czlMZEtxSmd4NVVBTQ?oc=5", "source_name": "Investing.com", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Participate in the Bank of America Securities 2026 Health Care Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPV09Ub1IzblUzZVVHM2NaZHFOMFB4TEZuYXhlZG9FUENtUG94MXVpdkc5SjF3TEt5bk1ZTmh6cHNvWEgtb0NjS2xvcVZSQ09HTmtmQmRLNXkwRVVNUlBCWldteHdTc0lsOW1MMl9JLUlwRTFUMXpHQV9nU2RSNDFpNDgxSGFGTmdZTWR1TnB1T3pKWWhfU3ZVTU1RQzd3WkE4NV9KSGV2YTRXY0lmNlY1M0xpNGlqWmZYVlN1dW02bmk?oc=5", "source_name": "Biogen", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen stock price target raised to $245 by Canaccord on Apellis deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPVnB0QjJjZlNOZTRjcnUwUU43N2M0Z2x4OW5LcVVTTmUwSWN6UmpSaWcwRzYwMDdLb0hsTkl4Mzc2U2poTUYzYkhjTTdaSjcwVEJ1cFV4U01ScG9jMWhsZ2VCU2lfQlloVk0xVVN5ODR5SWFJVzV0NWQxRzdnX1luOEtXai03M1BFdjM5VHZnT0czZGR1UzRJTnZBTHE2REh6b3RmUTZkR0ZkWnhRZjRkUG9HRzhJdDRNMlF0eUtRemloLXFMMFRF?oc=5", "source_name": "Investing.com", "published_at": "2026-04-01T07:00:00+00:00", "published_display": "01 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 64, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Acquire Apellis, Enhancing the Company\u2019s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOVEV0VlhLbzVMaGdWYjJJLVN4V0NIVnVidDk2NW9vRzVpTTNwVDBZTl9aQW9Xd0FKQ3JTeXBvcUZpSTFQNHEwN3NRX1FTeUdfdVNlYWpDZlREb1lOd0RVemRNUG5WRnlHN3R1czVXN2NteVFqeV9hYzZybXZZWVkwTDZSNlFrQmJtNFBOUjZqZU9jRXFRRmFhNE1oNkVfM1ZrWEFIZ2FQclpuYmRYV09jVDdGSDZKZ1BPYnhXZHNIZw?oc=5", "source_name": "Biogen", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to acquire Apellis Pharmaceuticals for $5.6B, adding C3 therapies to portfolio", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxPeTYyQXlmLXRZbEJRVURhb2tITmUzcWxfMUhiSjRCRjkxajItRGgyMDlxdUs3MG1wT3NpdUNhZUxCQzVpSVQzMTZuZjlhN1ZxazBiMHFveXBYbFhMSEJiUGNtb1JfSUpzQ3YzQ1l4SzBHTnp5STVMTFpNd05WSkk3c0xVelhfWmhDWjJ5QUc0QVhpNHpSekVmNnZpM1VkYjdDLVgtZllVVmpoLWFaZkp6U29sY0tyT1FKYVBqR29CTTdsb3BpMG1EVkM2UzlKTC1fM01YbGxYYWljRlZwZWNkN0JOV0xuZm1fRmc?oc=5", "source_name": "Proactive financial news", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Apellis Pharma Skyrockets on Biogen Deal. Is It Too Late to Chase APLS Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPakpLRXlsYVRWR0hmV0lxTm54MmVhZFQ1Nzg5V1owMnhSY2g3S3ROQTNnQUQ3UTlvWnZmdC16RkhPUXRaUGszeEdMMmxiUzVqMmdfSFc0MUdIT3Zva2lwdXNlMjQtS1ZsNFBoNWlJTzAyQ0tqVG44TjNNVnFOY2dLSENXajJ0Q2EzQ3A2c21KV2U1ekJRd3R2Nko5bUhBUEtGWGllMVU0U2dSRGFaNV9lY01JZ003SVFFWkZV?oc=5", "source_name": "Barchart.com", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen stock maintained at Buy by Jefferies on FDA Spinraza approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQenh4ZjE3VG9abkY1c0xnOTJFUEkzaTlWSDFqYTdYeVYtd1FKd2MyaVc0UlNSalJPdHRaR1dBdnNkUnhOVjJXZW9zcU95UWhPc0dCT3o0SjZzVlQyQXAtWTBHUFBGeW1fRHpiX1I2aHZnY3lSMVhGU2tvNkowTWtleXVROXRrTFdaak9LY3F4OXhadHdvVDRxRHJfdlpYMXkyRTBQN0NlUG0yZ1l2dnJXZGhobGpPM01QMi12ZC03NElnVW02aWQw?oc=5", "source_name": "Investing.com", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Stock: Is BIIB Outperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQV0JiVkxRdFA1THhONXZiQmJGUE43bk9lRlNCOEVEOHU5ZFBPTUlVLWFQTUk4NUk1eEtFekN4WXVWN3BPSkxkeTNKU1pJN0ZjSjRnU3R5OENncDJ6TDJFSVliTnpjemxla2hSNmlnX05LUGNPdDdFNzUzRnJwNlZpM3BoQWhhUGRxTC1wZ0FRRm9DNjN4clFOLVVDbWNxZjBY?oc=5", "source_name": "Barchart.com", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Share New SMA Data at Muscular Dystrophy Association and SMA Europe Conferences", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNRWZUUFdGSnJzeUhKM19mMGtuODF6NW11UTNfYTV2amdxT25zR1VQWlIyLVhtTUswV1VOWDR4cUNPRUFPdkJvOGo0cWxRUjBNN2NOaDg2Nk9UYlRseUVwWnkwWmpnNUFsMUVhOXYtcEtGRHM5MlJOVjhTYnJRX1NuQWxTX282ZDQ4Q0t2TVJJbTFYZ09fT2NYeG5pUVZiVzVLS2xwMldxWnBjTVFEZnF4aTlna0lMbUJ1N1FLWHRRYXhaalNNel93?oc=5", "source_name": "Biogen", "published_at": "2026-03-05T12:32:19+00:00", "published_display": "05 Mar 2026 12:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Acquisition of Alcyone Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNOGRybmhqVmpTUUxzQ2xtbEllRDNCdjdyREVVbjdyUEp1XzFaVl9zaFN2TUV2b1YtQXZLY0p2Ulc0eG9BaE9ZdDJ3SlJFVUczMzJMYXZFRHlmMlF1cG42V1RIY0ZLNmI4N2pIVFRLc2VLSGxrX0JVNGVybF9XRV9ZZFdMZXMtS3JNNGh4X3FqdDFqUUxLSWkzYTJiZFh0T3ItaTMxWGRmV0JSSUpKcWxoYjhnbw?oc=5", "source_name": "Biogen", "published_at": "2025-11-14T08:00:00+00:00", "published_display": "14 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 69, "total_relevant": 18, "sentiment_summary": {"positive": 6, "negative": 2, "neutral": 10, "score": 53, "total": 18, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 76, "events": [{"event": "general", "label": "Market update", "weight": 4.4, "count": 8}, {"event": "deals", "label": "Deals and strategy", "weight": 2.75, "count": 5}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 6, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 170.34, "latest_week": "2026-07-10", "one_week_move": -7.5, "four_week_move": 5.1, "twelve_week_move": 14.4, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.436176, "market_dynamics_buy_signal": false, "relative_strength": 4.478227, "fair_value_gap": 2.6, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "positive", "expectation_probability": 55.2846, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-7.5% over one week, +5.1% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 60, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Biogen", "count": 6}, {"label": "Investing.com", "count": 5}, {"label": "GuruFocus", "count": 2}, {"label": "PR Newswire", "count": 2}, {"label": "Barchart.com", "count": 2}, {"label": "Proactive financial news", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 18}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 8}, {"label": "Deals and strategy", "count": 5}, {"label": "Regulatory and legal", "count": 2}, {"label": "Analyst action", "count": 2}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "76/100 classification confidence."}, {"label": "Company focus", "value": "18", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-7.5% over one week, +5.1% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Biogen Inc (BIIB) Shares Fall 8.2% -- What GF Score of 74 Tells Investors"}], "updated_at": "2026-07-18T05:29:39.857841+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}